Marapharm Ventures Inc Share Price Deutsche Boerse AG
Equities
CA56575M1086
Healthcare Facilities & Services
Sales 2020 | 2.27 2.1 189.43 | Sales 2021 | 3.15 2.92 263.1 | Capitalization | 10.06M 9.33M 840M |
---|---|---|---|---|---|
Net income 2020 | -40M -37.09M -3.34B | Net income 2021 | -8M -7.42M -668M | EV / Sales 2020 | 1,35,92,488 x |
Net Debt 2020 | 5.3M 4.92M 443M | Net Debt 2021 | 13.31M 12.34M 1.11B | EV / Sales 2021 | 74,17,546 x |
P/E ratio 2020 |
-0.45
x | P/E ratio 2021 |
-1.08
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 71.26% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 18/20/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 08/20/08 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 339M | |
+34.02% | 277M | |
+39.53% | 182M | |
+156.53% | 145M | |
-33.33% | 137M | |
+50.41% | 136M | |
-28.57% | 121M | |
-7.69% | 80.3M | |
+100.00% | 60.26M |